Phio Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
November 14, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company exploring new pathways towards a cancer-free future by using its INTASYL ® siRNA gene silencing ...
Dublin Live on MSN50m
20-metre long giant newt Alf makes his way through streets of Dublin
Alf, a giant puppet of a smooth newt, has made the city his temporary home this week as an initiative of Science Week ...
Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company exploring new pathways towards a cancer-free future ...